Boston Scientific (BSX) Com Stk US $0.01

Sell:$61.26Buy:$61.27Price decreased$1.29 (2.06%)

Prices delayed by at least 15 minutes
Sell:$61.26
Buy:$61.27
Change:Price decreased$1.29 (2.06%)
Prices delayed by at least 15 minutes
Sell:$61.26
Buy:$61.27
Change:Price decreased$1.29 (2.06%)
Prices delayed by at least 15 minutes

Company Information

About this company

Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company's MedSurg segment includes Endoscopy, Urology, and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal conditions with less-invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, and incontinence. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. The Cardiology includes interventional cardiology therapies, watchman, cardiac rhythm management, and electrophysiology.

Key people

Michael F. Mahoney
Chairman of the Board, President, Chief Executive Officer
David C. Habiger
Independent Director
Jessica L. Mega
Independent Director
Susan E. Morano
Independent Director
Jonathan R. Monson
Chief Financial Officer, Executive Vice President
Miriam O' Sullivan
Chief Human Resources Officer, Senior Vice President
Vance R. Brown
Executive Vice President, General Counsel, Corporate Secretary
Arthur Crosswell Butcher
Executive Vice President, Group President, MedSurg and Asia Pacific
Joseph M. Fitzgerald
Executive Vice President, Group President - Cardiovascular
Padraig A. O'Connor
Executive Vice President - Global Operations
Edward J. Ludwig
Lead Independent Director
Yoshiaki Fujimori
Independent Director
Click to see more

Key facts

  • Shares in issue
    1.75bn
  • EPIC
    BSX
  • ISIN
    US1011371077
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • Market cap
    $92.98bn
  • Employees
    59,000
  • Exchange
    New York Stock Exchange
  • Index
    S&P 500, TR Equity United States Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.